Clinical outcomes of transarterial chemoembolization combined with durvalumab for advanced and metastatic biliary tract cancer
These results indicate promising efficacy and acceptable safety for the combination of TACE and durvalumab as a first-line treatment for advanced and metastatic BTC.
Authors
- Xuedong Sun (ORCID: https://orcid.org/0000-0002-2933-0201)
- Xu Lu (ORCID: https://orcid.org/0000-0002-2726-0430)
- Zeran Yang (ORCID: https://orcid.org/0000-0003-0615-0256)
- Yuefeng Hu (ORCID: https://orcid.org/0009-0003-9214-3833)
- Long Jin (ORCID: https://orcid.org/0000-0003-1361-6173)
- Guang Chen (ORCID: https://orcid.org/0000-0002-3885-5528)
- Wei Jian
- Tianhao Su
Institutions
- Capital Medical University (CN)
- Beijing Friendship Hospital (CN)
Publication Details
- Journal
- Future Science OA
- Published
- 2025-07-04
- DOI
- https://doi.org/10.1080/20565623.2025.2526947
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00